Sales decline 59.13% to Rs 48.74 crore
Net Loss of Panacea Biotec reported to Rs 6.85 crore in the quarter ended September 2022 as against net loss of Rs 22.37 crore during the previous quarter ended September 2021. Sales declined 59.13% to Rs 48.74 crore in the quarter ended September 2022 as against Rs 119.26 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales48.74119.26 -59 OPM %-12.97-14.63 -PBDT-0.61-15.89 96 PBT-6.85-22.37 69 NP-6.85-22.37 69Powered by Capital Market - Live News